<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>1 </plain></SENT>
<SENT sid="1" pm="."><plain>To test whether an ischemic insult increases the susceptibility to <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A (CsA)-induced neurotoxicity, we examined the effect of CsA on the minimal electroshock-induced <z:mp ids='MP_0000947'>convulsions</z:mp> in mice treated with a transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) for a short period (2 h) </plain></SENT>
<SENT sid="2" pm="."><plain>2 </plain></SENT>
<SENT sid="3" pm="."><plain>This MCAO produced small to mid-sized infarcted regions in the cerebral hemisphere with increasing post-operative days </plain></SENT>
<SENT sid="4" pm="."><plain>In MCAO mice, CsA (30 mg/kg, i.p.) elevated the incidence of minimal electroshock-induced <z:mp ids='MP_0000947'>convulsions</z:mp> to 90-100% over that in sham mice (20-30%) at 1-7 days but not 14 days post-surgery </plain></SENT>
<SENT sid="5" pm="."><plain>3 </plain></SENT>
<SENT sid="6" pm="."><plain>In light of these findings, the possibility that CsA increases the risk of <z:mp ids='MP_0000947'>convulsions</z:mp> in patients with <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and/or at an early stage following focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> would have to be considered </plain></SENT>
</text></document>